BIT.AX - Biotron Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
Total revenue
-
-
0.931
-
Gross profit
-
-
0.931
-
Operating expenses
Research development
1,974
1,116
1,693
3,155
Selling general and administrative
1,052
1,167
1,171
1,145
Total operating expenses
3,534
2,774
3,233
4,783
Operating income or loss
-3,534
-2,774
-3,233
-4,783
Total other income/expenses net
-
1,073
1,623
1,659
Income before tax
-3,423
-1,612
-1,594
-3,093
Income tax expense
0
0
0
0
Income from continuing operations
-3,423
-1,612
-1,594
-3,093
Net income
-3,423
-1,612
-1,594
-3,093
Net income available to common shareholders
-3,423
-1,612
-1,594
-3,093
Basic EPS
-
-0.00
-0.00
-0.01
Diluted EPS
-
-0.00
-0.00
-0.01
Basic average shares
-
559,287
397,150
365,700
Diluted average shares
-
559,287
397,150
365,700
EBITDA
-
-2,761
-3,221
-4,769